Page last updated: 2024-11-05

diazoxon

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

diazoxon: a pesticide; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

diazoxon : An organic phosphate that is diethyl hydrogen phosphate in which the hydrogen of the hydroxy group has been replaced by a 6-methyl-2-(propan-2-yl)pyrimidin-4-yl group. It is a metabolite of the pesticide diazinon. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID13754
CHEMBL ID1901616
CHEBI ID83533
SCHEMBL ID1525811
MeSH IDM0040890

Synonyms (30)

Synonym
phosphoric acid, diethyl 6-methyl-2-(1-methylethyl)-4-pyrimidinyl ester
diazoxon
962-58-3
diethyl 2-isopropyl-6-methylpyrimidin-4-yl phosphate
ccris 7775
NCGC00168301-01
diazinon-oxon
diethyl (6-methyl-2-propan-2-ylpyrimidin-4-yl) phosphate
NCGC00168301-02
unii-9fx08d2l1u
9fx08d2l1u ,
cas-962-58-3
NCGC00255024-01
dtxsid5037523 ,
tox21_301125
dtxcid3017523
CHEMBL1901616
chebi:83533 ,
diethyl 2-isopropyl-6-methylpyrimidin-4-ylphosphate
diethyl 6-methyl-2-(propan-2-yl)pyrimidin-4-yl phosphate
oxodiazinon
SCHEMBL1525811
diazinon oxon
phosphoric acid, diethyl 2-isopropyl-6-methyl-4-pyrimidinyl ester
VBLJFQYCTRKKKF-UHFFFAOYSA-N
diethyl 2-isopropyl-6-methyl-4-pyrimidinyl phosphate #
diazinon-oxon 100 microg/ml in acetonitrile
Q27156923
diethyl (2-isopropyl-6-methylpyrimidin-4-yl) phosphate
diethyl 4-methyl-2-isopropylpyrimid-6-yl phosphate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"A mechanistic toxicokinetic and toxicodynamic model for acute toxic effects (immobilization, mortality) of the organothiophosphate insecticide diazinon in Daphnia magna is presented."( Toxicokinetic and toxicodynamic model for diazinon toxicity--mechanistic explanation of differences in the sensitivity of Daphnia magna and Gammarus pulex.
Ashauer, R; Escher, BI; Hollender, J; Kretschmann, A, 2012
)
0.38
"Although primary toxic action of organophosphorous insecticides is associated with acetylcholinesterase inhibition, later studies suggest that oxidative stress may be responsible for induced organophosphates toxicity."( In vitro evaluation of neurotoxicity potential and oxidative stress responses of diazinon and its degradation products in rat brain synaptosomes.
Avramović, NS; Čolović, MB; Djurić, DM; Gajić, MM; Krstić, DZ; Vasić, VM, 2015
)
0.42
"Drinking water quality guideline values for toxic compounds are determined based on their acceptable daily intake."( Metabolism-Coupled Cell-Independent Acetylcholinesterase Activity Assay for Evaluation of the Effects of Chlorination on Diazinon Toxicity.
Kikkawa, Y; Matsui, Y; Matsushita, T; Omori, K; Shirasaki, N, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" From these results, we predicted that young animals would be more sensitive to diazinon, which, in fact, was the case: When postnatal day (PND) 17 or adult rats were given a dosage of 75 mg/kg diazinon, adult brain cholinesterase (ChE) was only inhibited 38%, while the brain ChE in the PND 17 animals showed much more inhibition (75%)."( Further assessment of an in vitro screen that may help identify organophosphorus pesticides that are more acutely toxic to the young.
Moser, VC; Padilla, S; Sung, HJ, 2004
)
0.32
" The PBK models were defined based on kinetic constants derived from in vitro incubations with liver fractions or plasma of rat and human, and were used to translate in vitro concentration-response curves for AChE inhibition obtained in the current study to predicted in vivo dose-response curves."( Physiologically based kinetic modelling based prediction of in vivo rat and human acetylcholinesterase (AChE) inhibition upon exposure to diazinon.
Rietjens, IMCM; Spenkelink, B; Wesseling, S; Zhao, S, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
marine xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound in marine macro- and microorganisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organic phosphate
pyrimidinesAny compound having a pyrimidine as part of its structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency7.97020.002541.796015,848.9004AID1347395; AID1347397; AID1347398; AID1347399
AR proteinHomo sapiens (human)Potency0.02820.000221.22318,912.5098AID588516
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency7.80720.001019.414170.9645AID743094
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency44.66840.023723.228263.5986AID588541
activating transcription factor 6Homo sapiens (human)Potency3.48730.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency49.259919.739145.978464.9432AID1159509
heat shock protein beta-1Homo sapiens (human)Potency22.00360.042027.378961.6448AID743210
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency24.48510.000627.21521,122.0200AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (49)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (6.12)18.7374
1990's4 (8.16)18.2507
2000's18 (36.73)29.6817
2010's19 (38.78)24.3611
2020's5 (10.20)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.67 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.04%)5.53%
Reviews3 (6.12%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (91.84%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]